Form 485BXT Cambria ETF Trust

 

AS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION ON JULY 7, 2022.

 

No. 811-22704

No. 333-180879

 

FORM N-1A

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

☒

 

Pre-Effective Amendment No.	☐
Post-Effective Amendment No. 184	☒

 

and/or

 

REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940

☒

 

Amendment No. 186

☒

 

(Check appropriate box or boxes)

 

CAMBRIA ETF TRUST

(Exact Name of Registrant as Specified in Charter)

 

2321 Rosecrans Avenue

Suite 3225

El Segundo, CA 90245

(Address of Principal Executive Offices, Zip Code)

 

(310) 683-5500

(Registrant’s Telephone Number, including Area Code)

 

Corporation Service Company

2711 Centreville Road

Suite 400

Wilmington, DE 19808

(Name and Address of Agent for Service)

 

Copy to:

W. John McGuire

Morgan, Lewis & Bockius LLP

1111 Pennsylvania Ave, NW

Washington, DC 20004

 

It is proposed that this filing will become effective (check appropriate box):

 

	☐	Immediately upon filing pursuant to paragraph (b)
	☒	On August 6, 2022 pursuant to paragraph (b)
	☐	60 days after filing pursuant to paragraph (a)(1)
	☐	On (date) pursuant to paragraph (a)(1)
	☐	75 days after filing pursuant to paragraph (a)(2)
	☐	On (date) pursuant to paragraph (a)(2) of Rule 485.

 

If appropriate, check the following box:

 

☒

This post-effective amendment designates a new effective date for a previously filed post-effective amendment.

 

 

EXPLANATORY NOTE

 

This Post-Effective Amendment No. 184 to the Registration Statement on Form N-1A for Cambria ETF Trust (the “Trust”) is being filed pursuant to paragraph (b)(1)(iii) of Rule 485 under the Securities Act of 1933 (the “1933 Act”) solely for the purpose of delaying, until August 6, 2022, the effectiveness of Post-Effective Amendment No. 122 (“PEA No. 122”), which was filed with the Commission via EDGAR Accession No. 0001615774-20-007570 on June 25, 2020, pursuant to paragraph (a)(2) of Rule 485 under the 1933 Act as it applies to the Cambria Africa ETF and Cambria Endowment Style ETF. Since no other changes are intended to be made to PEA No. 122 by means of this filing, Parts A, B and C of PEA No. 122, as indicated below, are incorporated herein by reference.

 

PART A – PROSPECTUS

 

The Prospectus for the Cambria Africa ETF and Cambria Endowment Style ETF is incorporated herein by reference to Part A of PEA No. 122.

 

PART B – STATEMENT OF ADDITIONAL INFORMATION

 

The Statement of Additional Information for the Cambria Africa ETF and Cambria Endowment Style ETF is incorporated herein by reference to Part B of PEA No. 122.

 

PART C – OTHER INFORMATION

 

The Part C for the Cambria Africa ETF and Cambria Endowment Style ETF is incorporated herein by reference to Part C of PEA No. 122.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended (“1933 Act”), and the Investment Company Act of 1940, as amended, the Registrant certifies that it meets all of the requirements for effectiveness of this registration statement pursuant to Rule 485(b) under the 1933 Act and has duly caused this Post-Effective Amendment No. 184 to the registration statement on Form N-1A to be signed on its behalf by the undersigned, duly authorized, in the City of El Segundo and State of California, on the 7^th day of July, 2022.

 

	CAMBRIA ETF TRUST
	By:	/s/ Mebane Faber
		Mebane Faber
		President

 

Pursuant to the requirements of the 1933 Act, this registration statement has been signed below by the following persons in the capacities and on the dates indicated.

 

SIGNATURE		TITLE		DATE
/s/ Ryan Johanson		Treasurer and Principal Financial		July 7, 2022
Ryan Johanson*		Officer (Principal Accounting Officer)
/s/ Mebane Faber		President and Trustee		July 7, 2022
Mebane Faber
/s/ Michael Venuto		Trustee		July 7, 2022
Michael Venuto*
/s/ Dennis G. Schmal		Trustee		July 7, 2022
Dennis G. Schmal*
*/s/ Mebane Faber
Mebane Faber
Attorney-in-Fact
Pursuant to Power of Attorney

 

 

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
• IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
• Aero Energy Reports on Recent Exploration Insights at the Sun Dog Project